InvestorsHub Logo
Followers 240
Posts 12423
Boards Moderated 0
Alias Born 08/14/2003

Re: FDApproved post# 34981

Thursday, 05/14/2020 2:08:18 PM

Thursday, May 14, 2020 2:08:18 PM

Post# of 44784
Given what we know about the bioreactor, wouldn't it make sense to treat it like the ventilators were where manufacturing was ramped up in making additional bioreactors, all under license from PSTI. It seems to me that if we had them, we could not only push the production of PLX-PAD, but could greatly accelerate vaccine production when one or more vaccines are determined effective if they're suited to production with our bioreactor.

As I see it, the need for PLX-PAD would potentially be for all who have pneumonia, which is substantial, but still a tiny fraction of the worlds total population which will ultimately need the vaccine. While the U.S.'s primary consideration may be protecting it's citizens, in reality if the entire world fails to get the vaccine it will lead to newly infected people who're traveling bringing it back to other places in the world. No vaccine is 100%, so each time the disease is reintroduced, some people will get it.

In watching the testimony of Dr. Bright it just reinforces how much better prepared we could have been if we listened to the scientists rather than the politicians. I'm embarrassed by the American efforts to date.

Gary